Lynae J Hanks
Overview
Explore the profile of Lynae J Hanks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanks L, Pelham J, Vaid S, Casazza K, Ashraf A
Diabetes Res Clin Pract
. 2016 Jun;
115:83-9.
PMID: 27242127
Aim: Diabetes-associated glucoregulatory derangements may precipitate atherogenesis in childhood and CVD risk, particularly with obesity. We aimed to delineate lipoprotein profile differences between children with type 1 and 2 diabetes...
2.
Hanks L, Simpson T, McCormick K, Casazza K
World J Clin Pediatr
. 2015 Nov;
4(4):50-4.
PMID: 26566477
Current pediatric obesity interventions have collectively yielded relatively unsuccessful results. In this Field of Vision, we present plausible physiologic underpinnings fostering ineffectiveness of conventional strategies grounded in requisite induction of...
3.
Hanks L, Ashraf A, Alvarez J, Beasley T, Fernandez J, Casazza K
Infant Child Adolesc Nutr
. 2015 Aug;
5(2):100-105.
PMID: 26236422
Currently, there is widespread interest in establishing 25-hydroxy vitamin D (25OHD) level preventing a secondary elevation in parathyroid hormone (PTH). The aim of this study was to identify the 25OHD...
4.
Hanks L, Gutierrez O, Bamman M, Ashraf A, McCormick K, Casazza K
J Clin Transl Endocrinol
. 2015 Jun;
2(2):77-82.
PMID: 26042208
Background: Circulating FGF21 levels are commonly elevated in disease states. There is limited information regarding concentrations of circulating FGF21 in the absence of disease, as well as age-related differences in...
5.
Hanks L, Gutierrez O, Ashraf A, Casazza K
J Pediatr
. 2015 Apr;
166(6):1397-403.
PMID: 25841541
Objective: To examine the associations of bone and bone-secreted factors with measures of energy metabolism in prepubertal and early pubertal boys. Study Design: Participants in this cross-sectional, observational study included...
6.
Hanks L, Casazza K, Judd S, Jenny N, Gutierrez O
PLoS One
. 2015 Mar;
10(3):e0122885.
PMID: 25811862
Introduction: Elevated fibroblast growth factor-23 (FGF23) is an established marker of cardiovascular disease. The underlying reason(s) for the rise accompanying cardiovascular health decline are unclear. Prior studies have shown that...
7.
Panwar B, Hanks L, Tanner R, Muntner P, Kramer H, McClellan W, et al.
Kidney Int
. 2014 Dec;
87(6):1216-22.
PMID: 25517912
Obesity is associated with chronic kidney disease progression. Whether metabolic risk factors modify this association is unclear. Here we examined associations of body mass index (BMI) and metabolic health with...
8.
Hanks L, Ashraf A, Gower B, Alvarez J, Casazza K
Bone Res
. 2014 Dec;
1.
PMID: 25505642
Little is known about early coincidental changes in bone and vascular properties, particularly in the context of skeletal anabolism (puberty) versus relative equilibrium (young adulthood). We aimed to determine if...
9.
Ashraf A, Alvarez J, Dudenbostel T, Calhoun D, Griffin R, Wang X, et al.
PLoS One
. 2014 Dec;
9(12):e114689.
PMID: 25479358
Objective: The role of vitamin D in cardiovascular health remains debated as results have been inconsistent. Previous studies have not considered the bioavailability of 25-hydroxy vitamin D [25(OH)D]. Objectives of...
10.
Casazza K, Hanks L, Fields D
Bonekey Rep
. 2014 Oct;
3:577.
PMID: 25328673
Human breast milk (HBM) contains numerous bioactive components, recently shown to be associated with growth and body composition in breastfed offspring. Reciprocity in adipogenic and osteogenic pathways suggests bone mass...